Israel - English - Ministry of Health

medison pharma ltd - sapropterin dihydrochloride - tablets soluble - sapropterin dihydrochloride 100 mg - sapropterin - sapropterin - kuvan is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment.kuvan is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.

European Union - English - EMA (European Medicines Agency)

biomarin international limited - sapropterin dihydrochloride - phenylketonurias - other alimentary tract and metabolism products, - kuvan is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment.kuvan is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.

Israel - English - Ministry of Health

medison pharma ltd - sapropterin dihydrochloride - tablets soluble - sapropterin dihydrochloride 100 mg - sapropterin - kuvan is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment.kuvan is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.

Israel - English - Ministry of Health

medison pharma ltd - sapropterin dihydrochloride - tablets soluble - sapropterin dihydrochloride 100 mg - sapropterin - kuvan is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment.kuvan is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.

European Union - English - EMA (European Medicines Agency)

dipharma arzneimittel gmbh - sapropterin dihydrochloride - phenylketonurias - other alimentary tract and metabolism products, - sapropterin dipharma is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment.sapropterin dipharma is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.

Canada - English - Health Canada

biomarin international limited - sapropterin dihydrochloride - tablet - 100mg - sapropterin dihydrochloride 100mg - other miscellaneous therapeutic agents

Canada - English - Health Canada

biomarin international limited - sapropterin dihydrochloride - powder - 100mg - sapropterin dihydrochloride 100mg - other miscellaneous therapeutic agents

Canada - English - Health Canada

biomarin international limited - sapropterin dihydrochloride - powder - 500mg - sapropterin dihydrochloride 500mg - other miscellaneous therapeutic agents

Canada - English - Health Canada

dr reddy's laboratories ltd - sapropterin dihydrochloride - powder for solution - 100mg - sapropterin dihydrochloride 100mg

Canada - English - Health Canada

dr reddy's laboratories ltd - sapropterin dihydrochloride - powder for solution - 500mg - sapropterin dihydrochloride 500mg